Trial
NCT04362293
Reduced Intensity Transplantation for Severe Sickle Cell Disease
Phase IISUSPENDEDOPERATIONALConfidence: HIGH
Sponsor
St. Jude Children's Research Hospital
Collaborators
—
Condition
Sickle Cell Disease
Intervention
hydroxyurea, azathioprine, alemtuzumab, thioptepa, low dose total body irradiation and sirolimus
Why stopped
We are holding enrollment, due to some recent SAEs.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-08-14